Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Diabetes management ... “An insulin pen, which contains a cartridge that holds the insulin, is a convenient way for many ...
Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...
We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...
Krista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...
The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, Sanofi, and all insulin manufacturers to take urgent action to increase access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback